New Strategies for the Next Generation of Matrix-Metalloproteinase Inhibitors: Selectively Targeting Membrane- Anchored MMPs with Therapeutic Antibodies
被引:62
作者:
Devy, Laetitia
论文数: 0引用数: 0
h-index: 0
机构:
Merck Serono SA, CH-1211 Geneva 20, SwitzerlandMerck Serono SA, CH-1211 Geneva 20, Switzerland
MMP intervention strategies have met with limited clinical success due to severe toxicities. In particular, treatment with broadspectrum MMP-inhibitors (MMPIs) caused musculoskeletal pain and inflammation. Selectivity may be essential for realizing the clinical potential of MMPIs. Here we review discoveries pinpointing membrane-bound MMPs as mediators of mechanisms underlying cancer and inflammation and as possible therapeutic targets for prevention/treatment of these diseases. We discuss strategies to target these therapeutic proteases using highly selective inhibitory agents (i.e., human blocking antibodies) against individual membrane-bound MMPs.